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A nickel subsulf ide (Ni3S2) lung tumor  model  for the s tudy of metal carcinogenesis  was 
evaluated using intratracheally dosed B6C3F 1 mice. A preliminary s tudy of  the survival of  
mice 14 days  after a single intratracheal  dose of  Ni3S z displayed an LDs0 of 4 mg/kg. A 
lifetime s tudy was then initiated using five graded doses  of  Ni3S z or saline alone; adminis- 
tered once a week  for 4 weeks.  Animals  which survived more than 60 days after the final 
dose were evaluated by histopathology. The  s tudy was terminated 27 mon ths  after initiation 
when  - 5 0 %  of the control  animals had died. There  was no increase in neoplastic or non- 
neoplast ic lesions observed  in animals treated with Ni3S 2 nor  was there evidence of damage 
to the  organs of  the respiratory tract f rom this t reatment .  The lack of  significant biological 
response  appears  to be the result  of  relatively low tolerated dose,  efficient lung clearance,  
and repair  of  early lung lesions.  © 1986 Academic Press, Inc. 
INTRODUCTION 
Nickel has been the subject of many reviews of metal carcinogens IARC, 
1976/7; Flessel et al., 1979; Furst, 1977; Sunderman, 1973, 1976, 1978). In the 
past, increased incidences of lung and nasal sinus cancers have been associated 
with certain nickel refining operations (Cuckle et al., 1981). The agent(s) respon- 
sible for these cancers has not been identified but most of the high risk operations 
involved exposures to high concentrations of nickel subsulfide (Ni3S2). Animal 
studies have demonstrated nickel subsulfide to be a most potent form of nickel, 
which has produced cancers in laboratory animals using a variety of exposure 
routes, treatment regimens, and animal species (IARC, 1976/7; Flessel et al., 
1979; Furst, 1977; Sunderman, 1973). Most commonly, intramuscular injection 
has been utilized to produce a high frequency of sarcomas with relatively short 
latency periods. The latency period is reported to be a function of the adminis- 
tered dose. Sunderman (1973) reports that intramuscular or subcutaneous injec- 
tion of nickel subsulfide dust varying from 3 to 40 mg generally produced high 
incidences of local sarcomas (rhabdomyosarcomas and fibrosarcomas) with an- 
imal survival times of 30 weeks or greater. Although nickel carcinogenesis has 
been well studied in laboratory animals by intramuscular, intrarenal, or other in- 
jection route, few studies have evaluated the effects on the respiratory tract of 
nickel subsulfide. 
The IARC monograph (1976/7) on nickel and nickel compounds indicates that 
intratracheal instillation of nickel powder, nickel subsulfide powder (mean par- 
ticle diameter 10 txm), or nickel oxide did not produce a significant increase in 
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tumor incidence in mice, rats, or hamsters, respectively. Inhalation studies with 
relatively low concentrations of nickel subsulfide performed by Ottolenghi et al. 
(1974) demonstrated a significant increase in tumors of the lung, particularly ade- 
nomas, adenocarcinomas, and squamous cell carcinomas. In contrast, lifetime 
inhalation studies with Syrian golden hamsters exposed to green nickel oxide did 
not produce significant increases in tumor incidence (Wehner et al., 1975). The 
difference between the Ottolenghi study (Ottolenghi et al., 1974) and the Wehner 
study (Wehner et al., 1975) appears to be due to the difference in potency be- 
tween the two chemical forms of nickel. Because other investigators have been 
successful at producing a highly reproducible incidence of tumors at the site of 
injection with nickel subsulfide exposure, we investigated the possibility of devel- 
oping a nickel subsulfide lung tumor model for the study of mechanisms in metal 
carcinogenesis. The intratracheal route of exposure was chosen because of its 
simplicity, cost effectiveness, and reproducibility. 
MATERIALS AND METHODS 
Particle Preparation 
Ni3S2 was kindly supplied by INCO Limited. Analysis of the material by light 
microscopy showed that the samples were homogeneous on an individual particle 
basis with respect to both morphology and color. Particle size of all samples was 
too coarse for experimental use. Because of the importance of particle size in 
pulmonary response to particulate insults, size classification was employed to 
achieve a respirable size of nickel subsulfide. 
Powders were prepared for settling by repeated grinding in a carbon steel 
grinding chamber of a SPEX Model 8000 Mixer-mill until a major portion of the 
particles were less than the targeted 2-~m cutoff diameter. The powders were 
then suspended in pure grade ethanol and settled in an Andreasan pipet for 5 hr 41 
rain, the calculated time required to remove all particles greater than the cut-off 
size from the sampling zone. Fines were gently drawn off, centrifuged to remove 
excess solvent, and dried in an oven below the boiling point of the solvent. Par- 
ticle size and morphological purity were evaluated by light microscopy. X-Ray 
diffraction of the Ni3S 2 before and after size separation by sedimentation con- 
firmed that no other detectable contaminants or species were present. Particle 
size was determined by light microscopic evaluation with subsequent conversion 
to volume distribution by assuming all particles were spheres and multiplying the 
count by the cube of the geometric mean of the class boundaries. 
Delivery Sys tem 
For intratracheal instillations, a Gilman Pipetman 20-~1 micropipet was cali- 
brated using Fe203 particles (0.4 to 3.7 txm) in phosphate-buffered saline (PBS). A 
1 in. x 23-gauge sterile blunt needle was attached to the pipet and a 20-1xl sample 
of the Fe203 suspension withdrawn. Pipet delivery showed excellent precision 
and accuracy (<3% error). 
Animals  
B6C3F a mice were selected for study because of the extensive historical data 
available on neoplastic and nonneoplastic lesions in untreated control animals 
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(Ward et al., 1979). These animals have a very low incidence of spontaneous lung 
sarcomas (0.03% for males); bronchiolar adenoma and carcinomas were also low 
(7.7 and 5.0%, respectively). 
B6C3F 1 male mice, 5 weeks of age, were obtained from the National Cancer 
Institute as there were no commercial vendors available for this strain. Mice were 
housed five per cage in polycarbonate cages containing Absorb-dri bedding and 
filter tops. Purina Certified Lab Chow and water from the public water supply 
were available ad libitum. After viral screening and 3 weeks of quarantine, an- 
imals were determined to be in good health and free from disease. 
Intratracheal Instillations 
B6C3F1 male mice, 8 weeks of age, were anesthetized with 60 mg/kg sodium 
pentobarbitol and placed vertically on a specially fabricated holder (Ho and 
Furst, 1973). A fiberoptic light was used to illuminate the buccal cavity and the 
tracheal opening was visualized. A Gilman Pipetman with a sterile blunt 23-gauge 
needle affixed to it was inserted down the trachea to a point just anterior to the 
primary bifurcation and the dosing material slowly instilled. All dose volumes 
were 20 txl. Mice were maintained on the holder in a vertical position until normal 
breathing resumed. 
Statistical Evaluation 
Statistical analysis of the tumor incidence data (Table 4) was done using a 2 x 2 
contingency design. X 2 and Cochran-Armitage (linear trend) values were calcu- 
lated (Snedecor and Cochran, 1967). Linear regressions were also done. 
Experimental Design 
A preliminary lethality study was performed to aid in dose selection. Eight- 
week-old male B6C3F 1 mice were randomly assigned by body weight to treat- 
ment groups (10 mice per group) and were acutely exposed to a single graded 
dose of nickel subsulfide. Survival was quantified 14 days after treatment. 
For the chronic toxicity study, male mice (8 weeks of age) were randomly as- 
signed by body weight to six groups of 20 animals per group after viral screening 
and a 3-week quarantine. The mice were intratracheally instilled once weekly for 
4 weeks with either graded doses of Ni3S 2 suspended in saline or saline alone. 
The surviving animals were maintained for 27 months at which point the vehicle 
control population was reduced to 50% of the animals which survived 60 days 
after the initial dose administration. 
RESULTS 
Preliminary Study 
Eight-week-old male B6C3F 1 mice were intratracheally instilled with single 
graded doses of nickel subsulfide. Only one vehicle control animal died during 
dose administration. At the end of the study (Day 14) 50% of the animals were 
alive at the 4 mg/kg dose (Table 1). Because of the nature of the dose response 
and the design of the study, this dose was considered the LDs0 and was used to 
approximate the highest dose for the toxicity ,study. 
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T AB L E  1 
SURVIVAL OF B6C3F 1 MICE AFTER A SINGLE INTRATRACHEAL INSTILLATION OF Ni3S 2 OR SALINE 
Ni3S z dose (mg/kg) 
Day 
postdosing 0 4 20 100 
1 9/10 a 10/10 10/10 10/i0 
2 9/10 10/10 10/10 4/10 
5 9/10 8/10 6/10 1/10 
6 9/10 8/10 0/10 1/10 
7 9/10 6/10 0/10 1/10 
12 9/10 5/10 0/10 1/10 
14 9/10 5/10 0/10 1/10 
a Number of survivors/number treated. 
Lifetime Study 
Animals were randomized by body weight into six groups of 20 male mice after 
3 weeks of quarantine and negative titers to the following viruses: pneumonia 
virus of mice, reovirus type 3, mouse encephalomyelitis (GD VII), Kilham virus, 
polyoma, Sendai, minute virus of mice, ectro, mouse adenovirus, murine hepa- 
titis, and lymphocyte choriomengites. The mice were intratracheally instilled 
once weekly for the 4 weeks with the following doses of nickel subsulfide in sa- 
line: 0, 0.024, 0.056, 0.156, 0.412, or 1.1 mg/kg. 
Animals not surviving 60 days after final dosing were simply tabulated in the 
survival data for toxicity of the nickel. No final body weight, necropsy, or histo- 
pathology were studied for the animals that died during the first 60 days. Table 2 
lists the number of survivors at the 60-day period, and at 21 and 27 months, as 
well as the average body weights for each group at 27 months. 
Gross and histopathologic evaluation were made on organs and tissues from all 
T A B L E  2 
SURVIVAL OF B6C3F1 MICE AFTER INTRATRACHEAL ADMINISTRATION OF Ni3S z OR SALINE ONCE A 
WEEK FOR 4 WEEKS 
Ni3Sz Dose (mg/kg) 
Months after 
last dose 0 0.024 0.056 0.156 0.412 1.1 
2 18/20 a 15/20 20/20 13/20 17/20 9/20 
21 17/20 14/20 19/20 12/20 16/20 7/20 
27 9/20 7/20 14/20 9/20 14/20 6/20 
Body weight (g) 
37.2 b 37.7 39.1 36.4 37.9 39.1 
SD 5.4 1.9 4.8 5.3 3.3 4.8 
n 9 7 14 9 14 6 
Number of  survivors/number treated. 
b Average body weight of animals terminated at 27 months. 
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animals surviving the 60-day toxicity period with two exceptions. The tissues 
from one animal in the lowest dose group (0.024 mg/kg) and one animal in the 
0.412 mg/kg dose group were badly cannibalized at necropsy and were discarded. 
Control mice and those from the five dose groups were examined. Gross lesions 
were recorded and all tissues showing gross lesions were examined microscopi- 
cally. In addition, the following tissues were examined histopathologically: nasal 
turbinates (cross section), salivary gland, mandibular lymph node, trachea, 
esophagus, thyroid, parathyroid, lung, thymus, stomach, jejunum, colon, 
caecum, rectum, heart, liver, kidneys, and adrenals. 
Table 3 shows the neoplastic lesions found in each dose group and the controls. 
Table 4 summarizes more detailed information on the incidence of total tumors, 
benign tumors, and malignant tumors in all dose groups and controls. 
There was no evidence of a dose-related increase in tumor incidence in treated 
mice when compared to controls. Similarly, there was no dose-related increase in 
nonneoplastic lesions in treated animals versus controls. Particularly, there was 
no damage evident to organs of the respiratory tract. The nonneoplastic lesions 
either occurred in small numbers or in numbers normally expected in aged male 
B6C3F 1 mice. 
Tumor data from Table 4 were statistically analyzed using the following as- 
sumption: Animal deaths that occurred during the first 60 days after dosing were 
an acute toxic effect of the dose and the deaths were independent of tumor for- 
T A B L E  3 
T U M O R  I N C I D E N C E  I N  B 6 C 3 F  1 M I C E  A F T E R  I N T R A T R A C H E A L  A D M I N I S T R A T I O N  O F  N i 3 S  2 O N C E  A 
W E E K  F O R  4 W E E K S  
Ni3S 2 Dose  (mg/kg) 
Tumor type 0 0 . 0 2 4  0 . 0 5 6  0 . 1 5 6  0 . 4 1 2  1 .1  
Malignant lymphoma 5 1 5 5 5 1 
Hepatocel lular carcinoma 5 2 2 3 2 - -  
Hepatocel lular adenoma 3 5 9 7 8 4 
Subcutaneous undifferentiated 
sarcoma 1 . . . . .  
Subcutaneous f ibrosarcoma - -  2 4 1 - -  - -  
Alveolar/bronchiolar carcinoma 1 1 2 - -  - -  - -  
Alveolar/bronchiolar adenoma - -  3 3 - -  1 2 
Hemangiosarcoma - -  1 - -  - -  - -  2 
Dermal neurof ibrosarcoma 1 . . . . .  
Renal adenocarcinoma . . . . .  1 
Renal adenoma . . . .  1 
Gastric squamous cell papil loma 1 . . . . .  
Thyroid adenoma 2 . . . .  1 
Pheochromocytoma 2 - -  2 1 - -  - -  
Adrenal capsular adenoma - -  1 . . . .  
Subcutaneous f ibroma - -  1 . . . .  
Harderian gland adenoma 2 - -  1 - -  1 - -  
Total tumors 2 3  17 2 8  17 18 11 
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TABLE 4 
SUMMARY OF COMBINED TUMOR INCIDENCE IN B6C3F 1 MICE AFTER INTRATRACHEAL 
ADMINISTRATION OF Ni3S z ONCE A WEEK FOR 4 WEEKS 
Ni3S 2 Dose (mg/kg) 
0 0.024 0.056 0.156 0.412 1.1 
Total animals with primary tumors/ 
total primary tumors 17/23 14/17 17/28 12/17 13/18 7/11 
Total animals with benign tumors/ 
total benign tumors 8/10 5/10 10/15 6/8 10/11 5/7 
Total animals with malignant tumors/ 
total malignant tumors 12/13 5/7 12/13 9/9 6/7 3/4 
Total animals with metastatic tumorsa/ 
total metastatic tumors 9/10 l/1 6/6 4/4 3/4 2/2 
Total animals/dose group 18 14 20 13 16 9 
Malignant lymphoma in more than one tissue was considered metastatic. 
mation. An analysis of the tumor incidence in the animals was done using stan- 
dard X 2 and Armitage tests (Snedecor and Cochran, 1967). There were no signifi- 
cant differences found between the tumor incidence and dose. Linear regressions 
for the data were also not significant. 
DISCUSSION 
In our studies of the carcinogenicity of intratracheally instilled nickel subsul- 
fide in B6C3Ft mice, we were unable to demonstrate an increase in lung or other 
tumor incidence. Furthermore, lung morphology appeared normal in animals ex- 
posed to four once-weekly intratracheal instillations of nickel subsulfide begin- 
ning at 11 weeks of age. For the period beginning 60 days after administration of 
the final dosage of nickel subsulfide, survival was excellent, indicating minimal 
chronic toxicity by this route of exposure. Furthermore, observations of the an- 
imals throughout their lifetimes, body weight data, and light microscopic morpho- 
logical evaluations all indicated a complete recovery of animals surviving the ini- 
tial stages of dosage administration. Tumor incidence data for all treated and con- 
trol groups are consistent with our laboratory historical control data for B6C3F 1 
mice. It is clear that in our study we achieved dosages beyond the maximum 
tolerated dose since 1.1 mg/kg appeared to be the LD50,60. The study was termi- 
nated when vehicle controls achieved a mortality of approximately 50%. This 
occurred at 27 months of age. At this time, the average body weights between 
survivors within dosage groups were similar. 
It is interesting to contrast the results of this intratracheal administration with 
previous studies using other routes of administration. The intramuscular route is 
most efficient in producing tumors with a single injection, oftentimes eliciting 
well over a 50% tumor incidence at the site of injection (Sunderman, 1973). 
Dosages used with this route of exposure tend to range from 3 to 10 mg/animal in 
either mice or rats. The highest achievable dose in our study was 4.4 mg/kg, or 
0.11 mg/mouse. Similarly, intrarenal studies have produced approximately a 50% 
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incidence at the site of injection utilizing approximately 5 mg nickel subsulfide 
administered in a single injection in rats (Ho and Furst, 1973). Only one study has 
successfully produced neoplastic changes in lungs of rats exposed to nickel sub- 
sulfide (Ottolenghi et al., 1974). 
Ottolenghi et al. (1974) exposed male and female Fischer 344 rats to approxi- 
mately 1 mg/m 3 of fine nickel subsulfide particles. Animals were exposed for ap- 
proximately 80 weeks at 6 hr/day, 5 days/week. Nine of 110 males and 5 of 98 
females had malignant tumors of the lung. In contrast, an additional 8 males and 7 
females had benign adenomas of the lung. These authors also report a high inci- 
dence of nonmalignant lung changes, including hyperplasia of approximately 65% 
incidence compared to approximately 20% in controls, atypical hyperplasia of 
50% compared to approximately 15% in controls, and squamous metaplasia in 
approximately 20% compared to 5% in controls. 
The dose to the lung in the Ottolenghi study (Ottolenghi, et al., 1974) may be 
calculated using assumptions relative to the deposition of the inhaled aerosol and 
the minute volume of the animals. The deposition fraction is determined by the 
aerodynamic diameter of the test aerosol. The authors indicate that the aerosol 
had 75% of the particles less than 1 fxm in size. If we assume that the count 
median diameter of this aerosol was indeed 0.8 Ixm, and further assume a geo- 
metric deviation of approximately 1.8 (a dispersion typical of laboratory gener- 
ated aerosols), we may calculate the aerodynamic diameter assuming the density 
of nickel subsulfide at 5.8 g/cm 3. The resulting aerodynamic diameter is approxi- 
mately 5.5 p.m. Raabe et al. (1976) reported lung (pulmonary and bronchial) depo- 
sition of approximately 10% for slightly smaller monodisperse aerosols (3 ~xm) in 
laboratory rats. Assuming a minute volume of 0.10 liter per minute, the cumula- 
tive lung deposition is estimated to have been approximately 1.5 rag/rat, or ap- 
proximately 7 mg/kg. Our maximum dosages of approximately 0.1 mg/animal, or 
4 mg/kg, are substantially less than the calculated cumulative lung dose in the rat 
inhalation study. Furthermore, if the intratracheal dose regimen were to achieve a 
tumor incidence similar to that of the inhalation study, it is likely that we would 
not observe a significant increase in tumors because of the relatively small 
numbers of animals at the highest dosage. 
In contrast to the reports by Ottolenghi et al. (1974), we did not observe a 
significant increase in hyperplasia or metaplasia in the lungs of the intratracheally 
treated animals. We have performed studies of the pulmonary clearance of radio- 
labeled nickel subsulfide from Strain A/J mice (Valentine and Fisher, 1984). Lung 
clearance was observed to be biphasic with initial and final phase biological half- 
lives of 1.2 and 12.4 days, respectively. In previous unpublished studies, we have 
observed hyperplastic and fibrotic changes in mice 1-2 weeks after intratracheal 
administration of nickel subsulfide. Thus, it appears that the lack of significant 
pathology at 27 months is the result of rather efficient clearance mechanisms 
which remove most of the nickel subsulfide within 2 months after intratracheal 
exposure. Subsequently, respiratory tract lesions appear to be repaired after re- 
moval of the primary insult. 
In summary, we have performed studies to evaluate the utility of nickel subsul- 
fide intratracheal instillation in B6C3F1 mice as a model system for metal carci- 
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nogenesis of the lung. Our findings indicate that intratracheal administration once 
a week for 4 weeks of nickel subsulfide at concentrations as high as the LD50 does 
not produce significant late effects. In particular, neither malignant or benign 
tumors, nor other pathological changes in the lungs were observed in mice main- 
tained until 27 months of age. The lack of significant biological response appears 
to be the result of two primary factors: (1) efficient clearance of nickel subsulfide 
after intratracheal instillation and (2) repair of early lung lesions. 
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